Abnormal coronary vasomotion in hypertension: role of coronary artery disease

Department of Cardiology, University Hospital, Zurich, Switzerland.

OBJECTIVES: This study sought to evaluate the effect of dynamic exercise on coronary vasomotion in hypertensive patients in the presence and absence of coronary artery disease. BACKGROUND: Endothelial dysfunction with abnormal coronary vasodilation in response to acetylcholine has been reported in patients with arterial hypertension. METHODS: Coronary artery dimensions of a normal and stenotic vessel segment were determined in 64 patients by biplane quantitative coronary arteriography at rest and during supine bicycle exercise. Patients were classified into two groups: 20 patients without evidence of coronary artery disease (10 normotensive, 10 hypertensive [group 1]) and 44 patients with coronary artery disease (26 normotensive, 18 hypertensive [group 2]). Both groups were comparable with regard to clinical characteristics, serum cholesterol levels, body mass index, exercise capacity and hemodynamic data. RESULTS: Mean aortic pressure was significantly higher in hypertensive than normotensive patients. Exercise-induced vasodilation of the normal vessel segment was similar in normotensive and hypertensive patients without coronary artery disease (group 1), namely, +19% versus +20%. However, in hypertensive patients with coronary artery disease, exercise-induced vasodilation was significantly less in both normal and stenotic vessel segments than in normotensive subjects (+1% vs. +20% for normal [p < 0.003] and -20% vs. -5% for stenotic vessels [p < 0.025]). Administration of 1.6 mg of sublingual nitroglycerin at the end of exercise led to a normalization of the vasodilator response in normotensive as well as hypertensive patients. However, this response became progressively abnormal in group 2 when coronary artery disease was present. CONCLUSIONS: In the absence of coronary artery disease, the vasomotor response to exercise is normal in both normotensive and hypertensive patients. However, in hypertensive patients with coronary artery disease, an abnormal response of the coronary vessels can be observed, with a reduced vasodilator response to exercise in normal arteries but an enhanced vasoconstrictor response in stenotic arteries. This behavior of the epicardial vessels during exercise suggests the occurrence of endothelial dysfunction (i.e., functional defect) that is not evident in the absence of coronary artery disease. Nitroglycerin reverses impaired coronary vasodilation, but this effect is blunted in the presence of coronary artery disease (i.e., structural defect).

This article has been cited by other articles:

				A. L. Moens, I. Goovaerts, M. J. Claeys, and C. J. Vrints Flow-Mediated Vasodilation: A Diagnostic Instrument, or an Experimental Tool? Chest, June 1, 2005; 127(6): 2254 - 2263. [Abstract] [Full Text] [PDF]

				P. A. Kaufmann and P. G. Camici Myocardial Blood Flow Measurement by PET: Technical Aspects and Clinical Applications J. Nucl. Med., January 1, 2005; 46(1): 75 - 88. [Full Text] [PDF]

				M. Togni, S. Windecker, P. Wenaweser, D. Tueller, A. Kaisaier, W. Maier, B. Meier, and O. M. Hess Deleterious Effect of Coronary Brachytherapy on Vasomotor Response to Exercise Circulation, July 13, 2004; 110(2): 135 - 140. [Abstract] [Full Text] [PDF]

				W. Maier, S. Windecker, A. Kung, R. Lutolf, F. R. Eberli, B. Meier, and O. M. Hess Exercise-Induced Coronary Artery Vasodilation Is Not Impaired by Stent Placement Circulation, May 21, 2002; 105(20): 2373 - 2377. [Abstract] [Full Text] [PDF]

				M. Kelm Flow-mediated dilatation in human circulation: diagnostic and therapeutic aspects Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H1 - H5. [Full Text] [PDF]

				D. S. David, P. A. Kaufmann, and O. M. Hess Hypercholesterolemia, Abnormal Coronary Vasomotion, and Calcium Antagonists • Response Circulation, April 13, 1999; 99(14): 1922 - 1926. [Full Text] [PDF]

				J. Frielingsdorf, P. Kaufmann, T. Suter, R. Hug, and O. M. Hess Percutaneous Transluminal Coronary Angioplasty Reverses Vasoconstriction of Stenotic Coronary Arteries in Hypertensive Patients Circulation, September 22, 1998; 98(12): 1192 - 1197. [Abstract] [Full Text] [PDF]

				P. A. Kaufmann, J. Frielingsdorf, L. Mandinov, C. Seiler, R. Hug, and O. M. Hess Reversal of Abnormal Coronary Vasomotion by Calcium Antagonists in Patients With Hypercholesterolemia Circulation, April 14, 1998; 97(14): 1348 - 1354. [Abstract] [Full Text] [PDF]